Klinische und experimentelle Kardiologie
Offener Zugang

Abstrakt

Recurrent Complete Atrioventricular Block During Cisplatin Infusion: A Case Report

Turkay Ozcan, Cirit A and Kiykim A

Cisplatin is one of the most effective chemotherapeutic agents used in the treatment of malignancies. The clinical use of cisplatin is limited by its severe adverse effects. Acute or long term cardiotoxicity is the most important doselimiting toxicity of cisplatin Cases of angina, myocardial infarction, and atrial arrhythmia have been reported during continuous infusion of cisplatin, but atrioventricular block (AV) has not been reported. Herein, we report a case with recurrent AV block that developed during cisplatin infusion, for the first time.